Clinical Trial Update: Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating regulatory T cell therapy to induce liver transplant tolerance in patients with chronic rejection of a liver transplant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rejection

Drugs mentioned

• Regulatory T cell therapy (regulatory T cells)

Snippet

Sponsor: Nanjing Medical University | Conditions: Chronic Rejection of Liver Transplant | Phase 1 | Status: UNKNOWN